Literature DB >> 27521389

Nonsteroidal anti-inflammatory drug administration in children with history of wheeze.

Kendra Sih, Ran D Goldman.   

Abstract

QUESTION: A child in my clinic who recently sprained his ankle is experiencing pain and having trouble bearing weight on the affected leg. His mother has been giving him acetaminophen, as she was told never to use nonsteroidal anti-inflammatory drugs (NSAIDs) because of his pharmacologically controlled asthma. Is asthma in children a contraindication to giving NSAIDs? Is NSAID-exacerbated respiratory disease (NERD) a real entity? ANSWER: Nonsteroidal anti-inflammatory drugs are effective analgesic and antipyretic medications. While described in adults with some predisposing conditions, NERD has not been clearly described in a large number of children. Nonsteroidal anti-inflammatory drugs can be recommended to children with known wheeze who do not have a history of NERD reaction. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27521389      PMCID： PMC4982722     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  13 in total

Review 1.  Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs.

Authors:  M L Kowalski; R Asero; S Bavbek; M Blanca; N Blanca-Lopez; G Bochenek; K Brockow; P Campo; G Celik; J Cernadas; G Cortellini; E Gomes; E Niżankowska-Mogilnicka; A Romano; A Szczeklik; S Testi; M J Torres; S Wöhrl; J Makowska
Journal:  Allergy       Date:  2013-10-05       Impact factor: 13.146

2.  Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.

Authors:  Hacer Ilbilge Ertoy Karagol; Ozlem Yilmaz; Erdem Topal; Alper Ceylan; Arzu Bakirtas
Journal:  Int Forum Allergy Rhinol       Date:  2015-03-06       Impact factor: 3.858

3.  The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study.

Authors:  Jason S Debley; Edward R Carter; Ronald L Gibson; Margaret Rosenfeld; Gregory J Redding
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

Review 4.  Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice.

Authors:  Christine Jenkins; John Costello; Linda Hodge
Journal:  BMJ       Date:  2004-02-21

Review 5.  Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management.

Authors:  Andrew Szczeklik; Donald D Stevenson
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

6.  Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.

Authors:  Jessica P Rajan; Nathan E Wineinger; Donald D Stevenson; Andrew A White
Journal:  J Allergy Clin Immunol       Date:  2014-10-03       Impact factor: 10.793

Review 7.  EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.

Authors:  E Nizankowska-Mogilnicka; G Bochenek; L Mastalerz; M Swierczyńska; C Picado; G Scadding; M L Kowalski; M Setkowicz; J Ring; K Brockow; C Bachert; S Wöhrl; B Dahlén; A Szczeklik
Journal:  Allergy       Date:  2007-05-22       Impact factor: 13.146

8.  Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.

Authors:  F Gaber; K Daham; A Higashi; N Higashi; A Gülich; I Delin; A James; M Skedinger; P Gyllfors; M Nord; S-E Dahlén; M Kumlin; B Dahlén
Journal:  Thorax       Date:  2008-08-29       Impact factor: 9.139

9.  Samter's triad in childhood: a warning for those prescribing NSAIDs.

Authors:  Rohan Ameratunga; Nicholas Randall; Stuart Dalziel; Brian J Anderson
Journal:  Paediatr Anaesth       Date:  2013-06-20       Impact factor: 2.556

10.  NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.

Authors:  D R Morales; B Guthrie; B J Lipworth; C Jackson; P T Donnan; V H Santiago
Journal:  Allergy       Date:  2015-05-07       Impact factor: 13.146
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.